Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul 151-742, Korea.
Thromb Res. 2010 Jun;125(6):e281-4. doi: 10.1016/j.thromres.2009.12.024. Epub 2010 Feb 18.
Platelets are highly reactive components of the circulatory system. The cytoskeleton of a platelet is an important structure for platelet aggregation as stimulated by several agonists. An anticancer agent, taxol, has been suggested to exert platelet anti-aggregating activity by stabilizing microtubules during the aggregation process. An activity-guided fractionation was performed with a methanol extract of the leaves and twigs of Taxus cuspidata to isolate taxanes with platelet anti-aggregating effects. Compounds 1 to 7 - taxinine (1), taxinine A (2), taxinine B (3), 2-deacetoxytaxinine B (4), taxacin (5), taxchinin B (6), and taxol (7) - were obtained as the antiplatelet components of this plant. These taxane compounds present the possibility of securing new antiplatelet compounds which differ from currently available antiplatelet agents in chemical structure and possibly in mechanisms of action. All compounds showed stronger inhibitory effects than acetylsalicylic acid (ASA) on platelet aggregation induced by arachidonic acid (AA) (IC(50): 14.4, 64.5, 35.5, 16.0, 21.9, 28.6 and 48.2 versus 63.0microM) or U46619 (IC(50): 34.8, 24.9, 36.2, 35.0, 46.9, 71.9 and 68.7 versus 340microM). Compounds 1, 3, 4 and 5, with a cinnamoyl group at the C(5) position, showed strong inhibitory effects against AA-induced aggregation compared to compound 2 (with an -OH group at C(5)) or compounds with an oxetane ring at C(4),(5), such as compounds 6 and 7. All of the seven compounds were 5-13-fold more strongly inhibitory than ASA against U46619-induced aggregation.
血小板是循环系统中高度反应性的成分。血小板的细胞骨架是血小板聚集的重要结构,这一过程受多种激动剂的刺激。一种抗癌药物紫杉醇被认为通过在聚集过程中稳定微管来发挥血小板抗聚集活性。从 Taxus cuspidata 的叶和小枝的甲醇提取物中进行了活性导向的分离,以分离具有血小板抗聚集作用的紫杉烷类化合物。化合物 1 至 7 - 紫杉醇(1)、紫杉宁 A(2)、紫杉宁 B(3)、2-去乙酰基紫杉醇 B(4)、紫杉醇(5)、紫杉辛宁 B(6)和紫杉醇(7) - 作为这种植物的抗血小板成分被获得。这些紫杉烷化合物提供了获得新的抗血小板化合物的可能性,这些化合物在化学结构上与目前可用的抗血小板剂不同,并且在作用机制上可能也不同。所有化合物对由花生四烯酸(AA)(IC50:14.4、64.5、35.5、16.0、21.9、28.6 和 48.2 对乙酰水杨酸(ASA))或 U46619(IC50:34.8、24.9、36.2、35.0、46.9、71.9 和 68.7 对 340μM)诱导的血小板聚集的抑制作用均强于 ASA。具有 C(5)位肉桂酰基的化合物 1、3、4 和 5 对 AA 诱导的聚集的抑制作用强于具有 C(5)位-OH 基团的化合物 2 或具有 C(4)、(5)位氧杂环丁烷环的化合物,如化合物 6 和 7。所有七种化合物对 U46619 诱导的聚集的抑制作用均比 ASA 强 5-13 倍。